LMNVX
Price
$132.41
Change
-$0.05 (-0.04%)
Updated
Sep 16 closing price
Net Assets
3.91B
VIVAX
Price
$71.93
Change
-$0.07 (-0.10%)
Updated
Sep 16 closing price
Net Assets
202.84B
Interact to see
Advertisement

LMNVX vs VIVAX

Header iconLMNVX vs VIVAX Comparison
Open Charts LMNVX vs VIVAXBanner chart's image
ClearBridge Value I
Price$132.41
Change-$0.05 (-0.04%)
VolumeN/A
Net Assets3.91B
Vanguard Value Index I
Price$71.93
Change-$0.07 (-0.10%)
VolumeN/A
Net Assets202.84B
LMNVX vs VIVAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
LMNVX vs. VIVAX commentary
Sep 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LMNVX is a StrongBuy and VIVAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIVAX has more cash in the bank: 203B vs. LMNVX (3.91B). VIVAX pays higher dividends than LMNVX: VIVAX (1.99) vs LMNVX (0.67). LMNVX was incepted earlier than VIVAX: LMNVX (31 years) vs VIVAX (33 years). LMNVX (0.80) is less costly to investors than VIVAX (0.17). LMNVX is a more actively managed with annual turnover of: 54.00 vs. VIVAX (9.00). VIVAX has a lower initial minimum investment than LMNVX: VIVAX (3000) vs LMNVX (1000000). VIVAX annual gain was more profitable for investors over the last year : 6.92 vs. LMNVX (2.20). VIVAX return over 5 years is better than : 72.48 vs. LMNVX (46.82).
LMNVXVIVAXLMNVX / VIVAX
Total Expense Ratio0.790.17465%
Annual Report Gross Expense Ratio0.800.17471%
Fund Existence31 years33 years-
Gain YTD6.8059.04175%
Front LoadN/AN/A-
Min. Initial Investment1000000300033,333%
Min. Initial Investment IRAN/AN/A-
Net Assets3.91B203B2%
Annual Yield % from dividends0.671.9934%
Returns for 1 year2.206.9232%
Returns for 3 years23.2538.4760%
Returns for 5 years46.8272.4865%
Returns for 10 years94.92138.0769%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SBSPX51.39N/A
N/A
Franklin S&P 500 Index A
SCNUX12.01N/A
N/A
Invesco Income Advantage U.S. Fund Inv
MBCGX22.03N/A
N/A
MassMutual Blue Chip Growth A
SHPCX12.82N/A
N/A
Saratoga Health & Biotechnology C
PCCOX65.78N/A
N/A
T. Rowe Price U.S. Equity Research I